Brunswick, Maine, U.S.A.-based Salmonics, which produces reagents and products from blood harvested from farmed salmon, has come a long way from operating out of a former paint room on a defunct U.S. Naval Air Force base.
When Salmonics President and CEO Cem Giray began the company in 2020, it tapped into space available at the former base, which was in need of renovation before it could be used as a space to produce biomedical reagents.
